Two Drugs Equal in Preventing Early Breast Cancer’s Return: Study
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozoleContinue Reading
Women with ductal carcinoma in situ had similar outcomes with tamoxifen, anastrozoleContinue Reading
Noninvasive technique shows promise for detecting spread of skin cancerContinue Reading
Scheduling the operation soon as possible after diagnosis seems to raise odds for survival, study findsContinue Reading
Doctors should be on the lookout for signs of the mood disorder, researcher saysContinue Reading
Study suggests 21 percent greater odds of survival after 10 yearsContinue Reading
Designed for women diagnosed with breast cancer
Continue Reading
Researchers also found lower risk of complications that can interrupt breast cancer treatmentContinue Reading
Afinitor lowered risk by a third, while Xgeva lowered chances by 18 percent, researchers reportContinue Reading
Higher body mass index in mother also linked to worse performance by young men on running testContinue Reading
Flavoring compounds have been tied to a serious illness known as ‘popcorn lung’Continue Reading
Flavoring compounds have been tied to a serious illness known as ‘popcorn lung’Continue Reading
But experts caution that study doesn’t prove cause-and-effect relationship between the twoContinue Reading
But experts caution that study doesn’t prove cause-and-effect relationship between the twoContinue Reading
Specialized radiation, immunotherapy drug have removed signs of lesions on former president’s brainContinue Reading
© 2021 TheHealthCast.com - All Rights Reserved.